An Open-Label Drug-Drug Interaction Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of JNJ-31001074 in Healthy Subjects.

Trial Profile

An Open-Label Drug-Drug Interaction Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of JNJ-31001074 in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 May 2010

At a glance

  • Drugs Bavisant; Ketoconazole
  • Indications Attention-deficit hyperactivity disorder
  • Focus Pharmacokinetics
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 05 Jan 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 31 Oct 2009 Planned end date changed from 1 Nov 2009 to 1 Dec 2009 as reported by ClinicalTrials.gov.
    • 18 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top